Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice regarding the lapse in government funding and the NIH Clinical Center status has been added, and the page shows a revision note updating from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdds: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removes: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates add Revision: v3.3.3 and remove the HHS Vulnerability Disclosure link along with Revision: v3.3.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision from v3.2.0 to v3.3.2 appears on the page, a minor update that does not affect study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.